Merck ADC, licensed from China, hits mark in first big global trial
Merck’s recent endometrial cancer trial marks a significant milestone as the first of 17 late-stage…
Newswire
Høeg Fired in Latest FDA Shakeup; 20 People Die After Taking Amgen Drug
The recent dismissal of FDA official Høeg marks a significant leadership change within the agency,…
Merck’s ADC sac-TMT Achieves First Global Phase 3 Success Ahead of Schedule
Merck’s experimental antibody-drug conjugate (ADC) sac-TMT has successfully completed its first global Phase 3 study…
Supreme Court declines to hear IRA challenges from Novo, AZ and more
In a significant setback for the pharmaceutical industry, the United States Supreme Court has opted…
Supreme Court Rejects Legal Challenge to Medicare Drug Price Negotiation Program
WASHINGTON — The Supreme Court on Monday dealt a major blow to the brand drug…
U.S. Biotech Faces Dilemma Over Chinese Drug Partnerships Amid Record Investments
U.S. biotech firms are grappling with a significant dilemma regarding their relationships with Chinese drug…
Regeneron immunotherapy combo comes up short in melanoma trial
A two-drug regimen of Regeneron’s fianlimab and Libtayo didn’t significantly outperform Keytruda in a late-stage…
Daiichi, AstraZeneca’s Enhertu Breaks into Early Breast Cancer with Dual FDA Approvals
Enhertu, a joint product of Daiichi Sankyo and AstraZeneca, has achieved a significant milestone by…
Bristol Myers Considers Houston for Potential $1B Manufacturing Plant
Bristol Myers Squibb is actively exploring locations for a significant manufacturing facility in the United…
FDA Approves AstraZeneca’s Baxdrostat for Patients with Hypertension
The FDA has granted approval for AstraZeneca’s baxdrostat, a novel treatment targeting specific patients with…